Moderate-to-severe Atopic Dermatitis trials recruiting in Illinois

Fewer than 3 recruiting trials found.

All Moderate-to-severe Atopic Dermatitis trials nationally

Cities in Illinois

Recruiting trials in Illinois

• A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
  NCT07690371 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Illinois: Normal